Martindale Pharma agrees supply deal with Burton Hospitals NHS Foundation Trust

Martindale Pharma has announced a new multi-year exclusive manufacturing agreement with Burton Hospitals NHS Foundation Trust.

The deal will see the trust supply a number of Martindale Pharma's key specialty generic products, including Bismuth Iodoform Paraffin Paste and Lidocaine and Phenylephrine Topical Solution.

This follows two years of collaborative work with Burton Hospital, which has become established as one of the company's best-performing contract manufacturing partners.

Michael Clark, chief marketing officer at Martindale Pharma, said: "We believe this new agreement demonstrates how pharmaceutical companies can support NHS manufacturing units and offer patients the best drugs currently available on the market."

Martindale Pharma has also worked with University College London's School of Pharmacy and London North West Healthcare NHS Trust's Q3P Qualified Person Training Course, providing academic and practical training to NHS trainees.

As part of the course, the pharmaceutical packaging module is hosted annually at Martindale Pharma's Romford facility.